Comparison of COVID-19 Vaccine Policies in Italy, India, and South Africa
Open Access
Abstract
(1) Purpose: This study aimed to analyze coronavirus disease 2019 (COVID-19) vaccine policies and their effectiveness in Italy, India, and South Africa to provide empirical experience for vaccination and COVID-19 pandemic control. (2) Methods: The study systematically summarized the COVID-19 vaccine policies in Italy, India, and South Africa through public information available on the official websites of the World Health Organization and the ministries of health in these three countries. Total vaccinations, COVID-19 vaccination rates, rates of fully vaccinated, rates of booster-vaccinated, and total confirmed cases were selected for cross-sectional comparison of COVID-19 vaccination in these three countries. Daily cases per million, daily deaths per million, and the effective reproduction rate were calculated to measure the effectiveness of COVID-19 vaccine policies implementation in each of these three countries. (3) Results: Italy, India, and South Africa differ in the start date of COVID-19 vaccination, vaccine types, vaccine appointments, and whether vaccinations are free. The COVID-19 vaccination rates in these three countries varied widely, with Italy having the highest and South Africa the lowest. COVID-19 vaccination has had a positive effect on reducing daily deaths and stabilizing the effective reproduction rate. The three countries had experienced more than one outbreak spike due to the spread of new mutated strains since the start of COVID-19 vaccination. (4) Conclusions: This study concluded that responding to the COVID-19 pandemic requires active promotion of basic and booster vaccinations to comprehensively build up the population immune barrier. Promoting equitable distribution of COVID-19 vaccine internationally and solidarity and cooperation among countries maximizes global common interests. By combining vaccination with non-pharmaceutical interventions, the pandemic can be prevented and controlled comprehensively and systematically in three aspects: detection of the source of infection, reduction of transmission routes, and protection of susceptible populations.Keywords
Funding Information
- Natural Science Foundation of Guangdong Province (2022A1515011112)
This publication has 20 references indexed in Scilit:
- Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deploymentThe Lancet, 2021
- Mobility and the effective reproduction rate of COVID-19Journal of Transport & Health, 2021
- Policy disparities in fighting COVID-19 among Japan, Italy, Singapore and ChinaInternational Journal for Equity in Health, 2021
- Transcranial magnetic stimulation neurophysiology of patients with major depressive disorder: a systematic review and meta-analysisPsychological Medicine, 2020
- Roadmap for strengthening the vaccine supply chain in emerging countries: Manufacturers' perspectivesVaccine: X, 2020
- The Equitable Distribution of COVID-19 Therapeutics and VaccinesJAMA, 2020
- Developing Covid-19 Vaccines at Pandemic SpeedNew England Journal of Medicine, 2020
- The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreakJournal of Autoimmunity, 2020
- Commentary on Ferguson, et al., “Impact of Non-pharmaceutical Interventions (NPIs) to Reduce COVID-19 Mortality and Healthcare Demand”Bulletin of Mathematical Biology, 2020
- Complexity of the Basic Reproduction Number (R0)Emerging Infectious Diseases, 2019